Left Atrioventricular Coupling Index in Feline Hypertrophic Cardiomyopathy: Association with Disease Severity and

Tuğba Varlik1, Didem Algan1, Ryou Tanaka2

  • 1Department of Internal Medicine, Veterinary Faculty, Bursa Uludag University, 16059 Bursa, Türkiye.

Veterinary Sciences
|May 26, 2026
PubMed

Insights

The left atrioventricular coupling index (LACI) shows increasing severity in feline hypertrophic cardiomyopathy (HCM). However, LACI-ED has limited ability to predict feline arterial thromboembolism (FATE).

Area of Science:

  • Cardiology
  • Veterinary Medicine
  • Echocardiography

Background:

  • Hypertrophic cardiomyopathy (HCM) is the most common cardiac disease in cats, leading to significant morbidity and mortality.
  • Feline arterial thromboembolism (FATE) is a major complication of HCM.
  • Conventional echocardiographic indices may not fully represent the relationship between the left atrium (LA) and left ventricle (LV).

Purpose of the Study:

  • To evaluate the left atrioventricular coupling index at end-diastole (LACI-ED) in cats with HCM.
  • To assess the association between LACI-ED and HCM severity.
  • To determine the utility of LACI-ED in predicting FATE.

Main Methods:

  • Retrospective, cross-sectional observational study of 91 cats.
  • Cats were categorized into healthy controls, asymptomatic HCM (stages B1, B2), symptomatic HCM (stage C), and cats with FATE.
  • LACI-ED was calculated as the ratio of LA end-diastolic volume to LV end-diastolic volume using echocardiography.

Main Results:

  • LACI-ED progressively increased with HCM severity (p < 0.001).
  • LACI-ED correlated positively with LA size/volume and inversely with LV global longitudinal strain (GLS).
  • LACI-ED showed limited discriminatory performance for FATE (AUC = 0.575), despite being associated with higher odds of prevalent FATE (OR = 4.65, p = 0.020).

Conclusions:

  • LACI-ED reflects disease severity in feline HCM.
  • LACI-ED's utility for predicting thromboembolic risk in cats with HCM appears limited.
  • Further research is needed to clarify the role of LACI-ED in feline cardiac disease management.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...